Trevi Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -20.55M-26.05M-32.76M-33.94M
Depreciation and Depletion 0.02M0.04M0.05M0.05M0.04M0.08M0.09M
Share-based Compensation 0.50M1.13M2.42M2.54M2.33M2.25M3.59M
Gains from Investment Securities 0.01M0.10M0.08M0.03M0.17M0.30M
Cash from Operations -18.29M-23.09M-29.00M-28.95M-28.18M-31.71M-38.26M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.83M2.12M1.37M
Amortization of Deferred Charges 0.06M0.23M0.60M0.52M0.18M
Depreciation & Amortization (CF) 0.02M0.04M0.05M0.05M0.04M0.12M0.15M
Change in Working Capital
Change in Receivables 0.14M0.37M
Change in Account Payables 0.07M0.78M0.42M0.83M0.01M-1.05M1.60M
Change in Accured Expenses 0.77M1.42M-0.10M0.34M-0.64M0.05M2.56M
Other Working Capital Changes 1.34M0.24M-0.74M-0.34M0.60M2.85M-2.66M
Investing Activities
Capital Expenditures 0.16M0.01M0.03M0.16M0.14M0.04M
Change in Acquisitions & Divestments 19.00M69.50M76.97M
Cash from Investing Activities -0.16M-0.01M-0.03M-107.37M59.43M-21.53M
Financing Activities
Other financing activities 1.53M1.21M3.13M7.50M0.23M1.71M14.15M
Cash from Financing Activities 3.63M73.21M16.72M20.77M111.31M-7.91M61.48M
Additional items
Change in Cash -14.82M50.11M-12.31M-8.17M-24.24M19.81M1.70M
Free Cash Flow -18.45M-23.10M-29.03M-28.95M-28.33M-31.85M-38.29M
Net Cash Flow -14.82M50.11M-12.31M-8.17M-24.24M19.81M1.70M